Prognostic impact of<i>DDX41</i>germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO studyNicolas Duployez, Marie Sébert, Raphaël Itzykson et al.|Blood|2022Cited by 80
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 casesÈve Zakine, C. Deligny, Alexis Mathian et al.|Journal of the American Academy of Dermatology|2022Cited by 67